Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women

被引:38
作者
Aho, J
Hankins, C
Tremblay, C
Forest, P
Pourreaux, K
Rouah, F
Coutlée, F
机构
[1] Ctr Hosp Univ Montreal, Ctr Rech, Mol Virol Lab, Montreal, PQ H2L 4M1, Canada
[2] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada
[3] McGill Univ, Joint Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] Inst Natl Sante Publ Quebec, Direct Sante Publ Montreal Ctr, Montreal, PQ, Canada
[5] Ctr Hosp Univ Montreal, Dept Microbiol & Infectiol, Montreal, PQ H2L 4M1, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1086/420787
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the role of human papillomavirus (HPV) type 52 polymorphism in the persistence of HPV infection, which is a predictor for cervical lesions. Cervical samples obtained at 6-month intervals were tested for HPV-52 in 1055 women; 41, 12, and 58 women had persistent, transient, and unclassified HPV-52 infections, respectively. HPV-52 isolates were analyzed by polymerase chain-reaction sequencing of the long control region (LCR), E6, and E7 genes. Although age (odds ratio [OR], 0.90 [95% confidence interval {CI}, 0.81-0.99]), nonprototypic LCR (OR, 9.26 [95% CI, 2.1-41.7]), and E6 variant (OR, 7.04 [ 95% CI, 1.4-37]) were associated, in univariate analysis, with the persistence of HPV-52 infection, a nonprototypic LCR variant was the only independent predictor of it (OR, 14.1 [ 95% CI, 1.1-200]). In the latter variants, the loss of a binding site for a repressor of HPV expression was associated with the persistence of HPV infection (OR, 7.25 [ 95% CI, 1.67-31.25]).
引用
收藏
页码:46 / 52
页数:7
相关论文
共 31 条
[1]   Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women [J].
Ahdieh, L ;
Klein, RS ;
Burk, R ;
Cu-Uvin, S ;
Schuman, P ;
Duerr, A ;
Safaeian, M ;
Astemborski, J ;
Daniel, R ;
Shah, K .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06) :682-690
[2]   Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women [J].
Aho, J ;
Hankins, C ;
Tremblay, C ;
Lang, F ;
Forest, P ;
Pourreaux, K ;
Rouah, F ;
Coutlée, F .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (10) :1517-1527
[3]   Overexpression of C/EBPβ represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein [J].
Bauknecht, T ;
Shi, Y .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2113-2124
[4]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[5]  
Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249
[6]  
Coutlee F, 1997, J MED VIROL, V51, P42, DOI 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO
[7]  
2-S
[8]  
Coutlée F, 1999, J CLIN MICROBIOL, V37, P1852
[9]   Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant [J].
Da Costa, MM ;
Hogeboom, CJ ;
Holly, EA ;
Palefsky, JM .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09) :1229-1237
[10]   Persistent human papillomavirus infection and cervical neoplasia [J].
Ferenczy, A ;
Franco, E .
LANCET ONCOLOGY, 2002, 3 (01) :11-16